ERGEA HEALTHCARE LIMITED - Profile & Financials

Accounts Submitted 10 Sept 2025

Confirmation Statement Submitted 12 Jun 2025

Net assets £3.54M £2.25M 2023 year on year

Total assets £26.03M £5.78M 2023 year on year

Total Liabilities £22.48M £3.52M 2023 year on year

Charges 4

2 outstanding 2 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Unit 4 Ely Road Theale Reading RG7 4BQ England

Office (London)

67 Upper Berkeley St, London W1H 7QX

Telephone

0207 723 5241

info@medipasshealthcare.com

Website

medipasshealthcare.com

Credit Report

Discover ERGEA HEALTHCARE LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£7.49M

Increased by £4.47M (+148%)

Net Assets

£3.54M

Increased by £2.25M (+175%)

Total Liabilities

£22.48M

Increased by £3.52M (+19%)

Turnover

£16.41M

Decreased by £1.44M (-8%)

Employees

Increased by 3 (+20%)

Debt Ratio

86%

Decreased by 8 (-9%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

1 Allotment 2,520 Shares £1.26m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
1 Jul 2016	ORDINARY	2,520	£1.26m	£500

Officers

4 active 4 resigned

Show resigned officers

						Status
David Anthony Rolfe	Director	British	England	53	15 Oct 2025	Active
John Edward Muolo	Director	British,american	United Kingdom	71	8 Dec 2010	Active
Michele Corti	Director	Italian	Italy	47	27 Nov 2020	Active
Victor James Wheeler	Director	British	England	54	15 Oct 2025	Active

Shareholders

Shareholders (3)


Medipass S.r.l.	94.2%	5,647	Ordinary (fully Paid)	15 Jun 2023
Medipass Srl	5.8%	350	Ordinary	15 Jun 2023
John Edward Muolo	0.0%	0	Ordinary	15 Jun 2023

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Dws Alternatives Global Limited

United Kingdom

Active

Notified 8 Sept 2020

Nature of Control

Significant Influence Or Control

Pan-european Infrastructure Iii Scsp

Ceased 5 May 2023

Ceased

Medipass Srl

Ceased 5 May 2023

Ceased

See All Controllers

Group Structure

DWS ALTERNATIVES GLOBAL LIMITED united kingdom

ERGEA HEALTHCARE LIMITED Current Company

ERGEA LEEDS LIMITED united kingdom shares 75 to 100 percent

Charges

2 outstanding 2 satisfied

Documents

Company Filings

Date	Category	Description	Document
16 Oct 2025	Officers	Appointment of Mr David Anthony Rolfe as director on 2025-10-15	View(2 pages)
16 Oct 2025	Address	Change Registered Office Address Company With Date Old Address New Address	View(1 page)
16 Oct 2025	Officers	Appointment of Mr Victor James Wheeler as director on 2025-10-15	View(2 pages)
16 Oct 2025	Officers	Termination of Guglielmo Brayda Di Soleto as director on 2025-10-15	View(1 page)
10 Sept 2025	Accounts	Annual accounts made up to 2024-12-31	View(58 pages)